DarioHealth Corp. DRIO
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -3.58% | -17.30% | -31.21% | -32.55% | -14.16% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -3.58% | -17.30% | -31.21% | -32.55% | -14.16% |
| Cost of Revenue | -8.37% | 10.63% | 6.24% | -17.76% | -12.97% |
| Gross Profit | -0.79% | -29.01% | -45.63% | -38.79% | -14.84% |
| SG&A Expenses | -10.33% | -11.53% | -11.44% | -12.33% | -30.44% |
| Depreciation & Amortization | -58.89% | -79.77% | -85.95% | -86.53% | -64.88% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -19.99% | -20.22% | -25.62% | -25.51% | -35.09% |
| Operating Income | 29.58% | 22.32% | 21.73% | 21.16% | 43.18% |
| Income Before Tax | 41.52% | 11.00% | 5.58% | 15.21% | 4.56% |
| Income Tax Expenses | -- | 159.09% | -46.45% | -- | -- |
| Earnings from Continuing Operations | 39.00% | 10.60% | 6.24% | 15.12% | 4.56% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 39.00% | 10.60% | 6.24% | 15.12% | 4.56% |
| EBIT | 29.58% | 22.32% | 21.73% | 21.16% | 43.18% |
| EBITDA | 28.98% | 16.78% | 8.81% | 9.74% | 41.49% |
| EPS Basic | 92.58% | 85.96% | 17.99% | 39.75% | -575.25% |
| Normalized Basic EPS | 84.47% | 67.98% | 49.00% | 45.39% | 23.40% |
| EPS Diluted | 92.58% | 85.96% | 17.99% | 39.75% | -575.25% |
| Normalized Diluted EPS | 84.47% | 67.98% | 49.00% | 45.39% | 23.40% |
| Average Basic Shares Outstanding | 276.53% | 177.91% | 100.58% | 55.28% | 24.60% |
| Average Diluted Shares Outstanding | 276.53% | 177.91% | 100.58% | 55.28% | 24.60% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |